Background
Current clinical treatment options for symptomatic, partial-thickness rotator cuff tear (sPTRCT) offer only limited potential for true tissue healing and improvement of clinical
Conclusion
Injection of UA-ADRCs can result in regeneration of injured human tendons by formation of new tendon tissue.